Health and Happiness (H&H) International Holdings (8BI) Stock Price & Analysis
8BI Stock Chart & Stats
- Day’s Range
- EUR 2.70 - EUR 2.70
- 52-Week Range
- EUR 1.10 - EUR 2.72
- Previous Close
- EUR 2.72
- Volume
- 0
- Average Volume (3M)
- 9
- Market Cap
- EUR 1.76B
- Enterprise Value
- EUR 13.15B
- Total Cash (Recent Filing)
- EUR 1.99B
- Total Debt (Recent Filing)
- EUR 7.72B
- Price to Earnings (P/E)
- 17.7
- Beta
- 0.47
- Next Earnings
- Mar 23, 2027 (Est.)
- EPS Estimate
- N/A
- Next Dividend Ex-Date
- N/A
- Dividend Yield
- 6.17%
Bulls Say, Bears Say
Bulls Say
Strong Gross Margins
Gross margins of roughly 60–64% indicate the branded nutrition portfolio retains meaningful economics after product costs. This provides a durable foundation for funding marketing, distribution, and product development, while offering some resilience if revenue growth remains moderate.
Consistent Free Cash Flow
Strongly positive free cash flow across the period demonstrates that the business converts its operations into usable cash. The approximately HK$0.95B generated in 2025 can support investment, shareholder returns, and gradual balance-sheet improvement when profitability stabilizes.
Branded Product Portfolio
A portfolio spanning infant nutrition, adult nutrition, and wellness gives H&H multiple branded consumer health categories rather than dependence on one product type. Its mix of e-commerce and retail channels also supports broad access to consumers and recurring product sales.
Bears Say
Elevated Leverage
Persistent debt-to-equity near 1.5–1.6 reduces financial flexibility and makes the company more sensitive to earnings fluctuations. Higher leverage can constrain investment and capital allocation, while weaker returns make balance-sheet improvement more dependent on sustained cash generation.
Earnings Volatility
The swing from healthy earlier profits to a 2024 loss, followed by only a thin 2025 recovery, shows that earnings power has not yet normalized. A net margin near 1.4% leaves limited room for cost, pricing, or product-mix pressure to absorb further shocks.
Weak Returns And Cash Coverage
Low returns on equity and declining free cash flow weaken the pace at which H&H can build capital internally. Operating cash flow coverage of debt near 0.22 also suggests that deleveraging may be gradual, leaving the business exposed if earnings remain volatile.
Health and Happiness (H&H) International Holdings News
8BI FAQ
What was Health and Happiness (H&H) International Holdings’s price range in the past 12 months?
What is Health and Happiness (H&H) International Holdings’s market cap?
When is Health and Happiness (H&H) International Holdings’s upcoming earnings report date?
How were Health and Happiness (H&H) International Holdings’s earnings last quarter?
Is Health and Happiness (H&H) International Holdings overvalued?
Does Health and Happiness (H&H) International Holdings pay dividends?
What is Health and Happiness (H&H) International Holdings’s EPS estimate?
How many shares outstanding does Health and Happiness (H&H) International Holdings have?
What happened to Health and Happiness (H&H) International Holdings’s price movement after its last earnings report?
Which hedge fund is a major shareholder of Health and Happiness (H&H) International Holdings?
What is the TipRanks Smart Score and how is it calculated?
Health and Happiness (H&H) International Holdings Stock Smart Score
Company Description
Health and Happiness (H&H) International Holdings
As an investment holding entity, Health and Happiness (H&H) International Holdings Limited specializes in the global production and distribution of nutritional and care products designed for families and infants. Its offerings are categorized into several key segments. The Infant Formulas division crafts nutritional formulas for children up to age seven, alongside specialized milk products for pregnant and breastfeeding women. The Probiotic Supplements division provides various forms of probiotics, including sachets, capsules, and tablets, catering to the needs of babies, children, and expecting mothers. Within its Adult Nutrition and Care Products segment, H&H develops and markets a range of items such as vitamins, general health supplements, skincare solutions, and sports nutrition for grown-ups. Complementing its infant offerings, the Other Pediatric Products segment focuses on manufacturing dried baby foods, additional nutritional supplements, and general baby care items. Furthermore, its Pet Nutrition and Care segment creates pet food, health-enhancing supplements, and bone broth products for animals. Beyond these core product lines, the company's activities extend to research, development, and processing of diverse ingredients like meat, fruit, and vegetable powders, as well as candies. It actively researches, develops, manufactures, and sells specialized nutritional foods, manages the marketing and distribution of organic baby foods, and handles the wholesale, retail, import, and export of infant nutritional and personal care products. H&H also engages in the trading and sale of adult vitamins, health supplements, probiotic skincare, and sports nutrition items, while offering online sales platforms, software and IT solutions, and packaging services. Its extensive product portfolio is marketed under well-known brands such as Biostime, Swisse, Aurelia, Zesty Paws, Solid Gold, Dodie, Good Gout, Aurelia London, and CBII. Established in 1999, the company adopted its current name, Health and Happiness (H&H) International Holdings Limited, in June 2017, having previously operated as Biostime International Holdings Limited. Headquartered in Quarry Bay, Hong Kong, H&H functions as a subsidiary of Biostime Pharmaceuticals (China) Limited.
- Sector
- Consumerdefensive
- Industry
- Packaged Foods
- CEO
- Akash Bedi
- Employees
- 2,758
- Website
- www.hh.global
- Address
- HK
Health and Happiness (H&H) International Holdings (8BI) Earnings & Revenues
8BI Company Deck
8BI Stock 12 Month Forecast
Average Price Target
Technical Analysis
Overall Consensus
| Indicator | Bullish | Neutral | Bearish |
|---|---|---|---|
| Overall Consensus | 15 | 1 | 6 |
| Technical Analysis | 3 | 1 | 6 |
| Moving Averages | 12 | 0 | 0 |